Condition: Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX · Sponsor: Lithuanian University of Health Sciences
Phase II, Multicenter, Open-label, Randomized Study evaluating neoadjuvant chemotherapy (FOLFOX4) in patients with stage II and III colorectal cancer with standard chemoradiation Defined by Magnetic Resonance Imaging
This description comes directly from the study's public registry record.
Rita Ambraziene · +37037326196 · rita.ambraziene@gmail.com
Always discuss trial participation with your own doctor first.
| Rita Ambraziene | Kaunas, Lithuania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05378919